Get the Stockscreener App
337.29
0.16%
-0.53
After Hours:
337.83
0.54
+0.16%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $337.29, with a volume of 1.47M.
It is down -0.16% in the last 24 hours and down -6.49% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$337.82
Open:
$340.31
24h Volume:
1.47M
Relative Volume:
0.96
Market Cap:
$65.43B
Revenue:
$321.33B
Net Income/Loss:
$1.57B
P/E Ratio:
42.42
EPS:
7.9518
Net Cash Flow:
$3.21B
1W Performance:
-3.82%
1M Performance:
-6.49%
6M Performance:
+18.78%
1Y Performance:
+40.24%
1-Day Range:
$337.12
$342.60
1-Week Range:
$333.39
$352.14
52-Week Range:
$223.92
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
337.29 | 65.53B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
795.01 | 98.49B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
198.00 | 47.25B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
74.44 | 8.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.34 | 741.42M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
How Is Cencora’s Stock Performance Compared to Other Medical Stocks? - MSN
Lombard Odier Asset Management USA Corp Invests $3.16 Million in Cencora, Inc. $COR - MarketBeat
Gabelli Funds LLC Reduces Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Stock Holdings Boosted by Axa S.A. - MarketBeat
Walleye Capital LLC Boosts Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by California Public Employees Retirement System - MarketBeat
Will Cencora Inc stock beat revenue estimatesQuarterly Trade Review & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Cencora Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Federated Hermes Inc. Increases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Burgundy Asset Management Ltd. Sells 157,024 Shares of Cencora, Inc. $COR - MarketBeat
Marshall Wace LLP Has $96.66 Million Holdings in Cencora, Inc. $COR - MarketBeat
Cencora's Healthcare Bio Logistics Strategy - Healthcare Digital
Amundi Has $500.89 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? - sharewise.com
Cencora Sees Unusually High Options Volume (NYSE:COR) - MarketBeat
Iterum Therapeutics Provides Business Update - GlobeNewswire Inc.
Why Cencora Inc. stock appears on watchlistsJuly 2025 Trends & Risk Controlled Daily Trade Plans - Newser
Cencora, Inc. $COR Shares Sold by First Trust Advisors LP - MarketBeat
Beutel Goodman & Co Ltd. Sells 177,824 Shares of Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock could break out in 20252025 Pullback Review & Real-Time Stock Price Movement Reports - Newser
Why Cencora Inc. stock is in analyst buy zoneJuly 2025 Reactions & High Yield Stock Recommendations - Newser
How rising interest rates impact Cencora Inc. stockPortfolio Return Report & AI Powered Market Entry Ideas - Newser
Cencora, Inc. (NYSE:COR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is Cencora Inc. (ABG) stock supported by strong fundamentalsJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
Is Cencora (COR) Quietly Rewriting Its Moat With an Aggressive Bet on Cryogenic Logistics? - simplywall.st
Cencora (NYSE:COR) Stock Price Down 4.6%Should You Sell? - MarketBeat
How Cencora Inc. stock compares with market leadersTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will Cencora Inc. (ABG) stock attract long term capital inflowsJuly 2025 Final Week & Reliable Momentum Entry Alerts - Newser
Can Cencora Inc. stock deliver consistent earnings growth2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - Newser
Cencora Inc. Stock Slips 4.4%, Underperforms Peers - 富途牛牛
Why Cencora Inc. (ABG) stock stays on top picks2025 Market Overview & Weekly Market Pulse Updates - Newser
M&T Bank Corp Increases Position in Cencora, Inc. $COR - MarketBeat
Why Cencora Inc. stock could be top winnerInflation Watch & Fast Exit and Entry Strategy Plans - Newser
How Cencora Inc. (ABG) stock reacts to stronger dollarMarket Volume Summary & Fast Exit and Entry Strategy Plans - Newser
Edgestream Partners L.P. Increases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Can Cencora Inc. stock deliver surprise earnings beatJuly 2025 Action & Risk Controlled Stock Alerts - Newser
Cencora Is Buying Big—But Can Its Acquisition Spree Deliver Massive Long-Term Growth? - Smartkarma
Why Cencora (COR) Shares Are Trading Lower Today - Finviz
JPMorgan raises Cencora (COR) price target after financial model update - MSN
Is Cencora Stock Built to Withstand More Downside? - Trefis
JPMorgan Raises Cencora (COR) Price Target After Financial Model Update - Insider Monkey
15 Dividend Stocks That Outperform the S&P 500 - Insider Monkey
Cencora, Inc. $COR is Isthmus Partners LLC's 3rd Largest Position - MarketBeat
Quantbot Technologies LP Raises Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Opens New 500,000 Square-Foot 3PL Facility In Texas - marketscreener.com
Can Cencora Inc. (ABG) stock surprise with quarterly resultsQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Invesco Ltd. Reduces Holdings in Cencora, Inc. $COR - MarketBeat
How Cencora Inc. (ABG) stock trades after rate cutsQuarterly Profit Review & Technical Pattern Based Signals - Newser
Is Cencora Inc. stock supported by strong cash flowsWeekly Trading Summary & Safe Entry Momentum Stock Tips - Newser
Can Cencora Inc. stock surprise markets with earningsQuarterly Portfolio Summary & AI Enhanced Execution Alerts - Newser
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.44%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):